Search research articles
Contact Us
Filters
Showing results (1-10 of 5) with videos related to
Page
of 1
Sort By:
Health Informatics Journal
|
January 24, 2020
A clinician's perspective on co-developing and co-implementing a digital tumor board solution
Richard D Hammer, Matthew S Prime
Plos One
|
May 13, 2022
Development and validation of ACTE-MTB: A tool to systematically assess the maturity of molecular tumor boards
Tara M Love, Daniel A Anaya, Matthew S Prime, et al.
JCO Clinical Cancer Informatics
|
August 21, 2020
Digital Tumor Board Solutions Have Significant Impact on Case Preparation
Richard D Hammer, Donna Fowler, Lincoln R Sheets, et al.
Journal of Cancer Research and Clinical Oncology
|
August 16, 2022
Adherence to guidelines-recommended diagnostic testing was associated with overall survival in patients with diffuse large B-cell lymphoma after rituximab-based treatment: an observational cohort study
Fei Yang, Ju Zhang, Anup Abraham, et al.
Cambridge Prisms. Precision Medicine
|
May 3, 2024
Challenges and solutions to system-wide use of precision oncology as the standard of care paradigm
Nesrine Lajmi, Sofia Alves-Vasconcelos, Apostolos Tsiachristas, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 5) with videos related to
Sort By:
Page
of 1
Health Informatics Journal
|
January 24, 2020
A clinician's perspective on co-developing and co-implementing a digital tumor board solution
Richard D Hammer, Matthew S Prime
Plos One
|
May 13, 2022
Development and validation of ACTE-MTB: A tool to systematically assess the maturity of molecular tumor boards
Tara M Love, Daniel A Anaya, Matthew S Prime, et al.
JCO Clinical Cancer Informatics
|
August 21, 2020
Digital Tumor Board Solutions Have Significant Impact on Case Preparation
Richard D Hammer, Donna Fowler, Lincoln R Sheets, et al.
Journal of Cancer Research and Clinical Oncology
|
August 16, 2022
Adherence to guidelines-recommended diagnostic testing was associated with overall survival in patients with diffuse large B-cell lymphoma after rituximab-based treatment: an observational cohort study
Fei Yang, Ju Zhang, Anup Abraham, et al.
Cambridge Prisms. Precision Medicine
|
May 3, 2024
Challenges and solutions to system-wide use of precision oncology as the standard of care paradigm
Nesrine Lajmi, Sofia Alves-Vasconcelos, Apostolos Tsiachristas, et al.
Page
of 1